APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharma Grade Polyvinylpyrrolidone

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharma Grade Polyvinylpyrrolidone Market Outlook and Growth Opportunities 2026

13 August 2026191 pages

Choose your research edition.

Industry ResearchPharma Grade Polyvinylpyrrolidone Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharma Grade Polyvinylpyrrolidone Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Pharma Grade Polyvinylpyrrolidone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharma Grade Polyvinylpyrrolidone Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharma Grade Polyvinylpyrrolidone Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Pharma Grade Polyvinylpyrrolidone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pharma Grade Polyvinylpyrrolidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharma Grade Polyvinylpyrrolidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharma Grade Polyvinylpyrrolidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pharma Grade Polyvinylpyrrolidone market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pharma Grade Polyvinylpyrrolidone market include BASF, Ashland, Boai NKY Medical Holdings, JH Nanhang Life Sciences, Chongqing Star-Tech Specialty Products, Huangshan Bonsun Pharmaceuticals, Shanghai Yuking Water Soluble Material Tech, Shanghai Qifuqing Material Technology and Jiaozuo Zhongwei Special Products Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pharma Grade Polyvinylpyrrolidone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharma Grade Polyvinylpyrrolidone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharma Grade Polyvinylpyrrolidone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pharma Grade Polyvinylpyrrolidone market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharma Grade Polyvinylpyrrolidone Segment by Company

BASF

Ashland

Boai NKY Medical Holdings

JH Nanhang Life Sciences

Chongqing Star-Tech Specialty Products

Huangshan Bonsun Pharmaceuticals

Shanghai Yuking Water Soluble Material Tech

Shanghai Qifuqing Material Technology

Jiaozuo Zhongwei Special Products Pharmaceutical

CNSIG Anhui Hongsifang Fertilizer

Pharma Grade Polyvinylpyrrolidone Segment by Type

K17

K25

K30

K90

Other

Pharma Grade Polyvinylpyrrolidone Segment by Application

Oral Preparations

Injectable Preparations

Topical Preparations

Others

Pharma Grade Polyvinylpyrrolidone Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharma Grade Polyvinylpyrrolidone status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pharma Grade Polyvinylpyrrolidone market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharma Grade Polyvinylpyrrolidone significant trends, drivers, influence factors in global and regions.

6. To analyze Pharma Grade Polyvinylpyrrolidone competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma Grade Polyvinylpyrrolidone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharma Grade Polyvinylpyrrolidone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma Grade Polyvinylpyrrolidone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pharma Grade Polyvinylpyrrolidone market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharma Grade Polyvinylpyrrolidone industry.

Chapter 3: Detailed analysis of Pharma Grade Polyvinylpyrrolidone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pharma Grade Polyvinylpyrrolidone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pharma Grade Polyvinylpyrrolidone in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharma Grade Polyvinylpyrrolidone Industry Trends Table 2. Pharma Grade Polyvinylpyrrolidone Industry Drivers Table 3. Pharma Grade Polyvinylpyrrolidone Industry Opportunities and Challenges Table 4. Pharma Grade Polyvinylpyrrolidone Industry Restraints Table 5. Global Pharma Grade Polyvinylpyrrolidone Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharma Grade Polyvinylpyrrolidone Revenue Share by Company (2021-2026) Table 7. Global Pharma Grade Polyvinylpyrrolidone Sales Volume by Company (t) & (2021-2026) Table 8. Global Pharma Grade Polyvinylpyrrolidone Sales Volume Share by Company (2021-2026) Table 9. Global Pharma Grade Polyvinylpyrrolidone Average Price (USD/t) of Company (2021-2026) Table 10. Global Pharma Grade Polyvinylpyrrolidone Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pharma Grade Polyvinylpyrrolidone Key Company Manufacturing Base & Headquarters Table 12. Global Pharma Grade Polyvinylpyrrolidone Company, Product Type & Application Table 13. Global Pharma Grade Polyvinylpyrrolidone Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pharma Grade Polyvinylpyrrolidone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of K17 Table 18. Significant Companies of K25 Table 19. Significant Companies of K30 Table 20. Significant Companies of K90 Table 21. Significant Companies of Other Table 22. Global Pharma Grade Polyvinylpyrrolidone Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 23. Global Pharma Grade Polyvinylpyrrolidone Sales Volume by Type (2021-2026) & (t) Table 24. Global Pharma Grade Polyvinylpyrrolidone Sales Volume by Type (2027-2032) & (t) Table 25. Global Pharma Grade Polyvinylpyrrolidone Sales Volume Share by Type (2021-2026) Table 26. Global Pharma Grade Polyvinylpyrrolidone Sales Volume Share by Type (2027-2032) Table 27. Global Pharma Grade Polyvinylpyrrolidone Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Pharma Grade Polyvinylpyrrolidone Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Pharma Grade Polyvinylpyrrolidone Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type (2021-2026) Table 31. Global Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Oral Preparations Table 33. Significant Companies of Injectable Preparations Table 34. Significant Companies of Topical Preparations Table 35. Significant Companies of Others Table 36. Global Pharma Grade Polyvinylpyrrolidone Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 37. Global Pharma Grade Polyvinylpyrrolidone Sales Volume by Application (2021-2026) & (t) Table 38. Global Pharma Grade Polyvinylpyrrolidone Sales Volume by Application (2027-2032) & (t) Table 39. Global Pharma Grade Polyvinylpyrrolidone Sales Volume Share by Application (2021-2026) Table 40. Global Pharma Grade Polyvinylpyrrolidone Sales Volume Share by Application (2027-2032) Table 41. Global Pharma Grade Polyvinylpyrrolidone Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Pharma Grade Polyvinylpyrrolidone Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Pharma Grade Polyvinylpyrrolidone Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application (2021-2026) Table 45. Global Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application (2027-2032) Table 46. Global Pharma Grade Polyvinylpyrrolidone Sales by Region: 2021 VS 2025 VS 2032 (t) Table 47. Global Pharma Grade Polyvinylpyrrolidone Sales by Region (2021-2026) & (t) Table 48. Global Pharma Grade Polyvinylpyrrolidone Sales Market Share by Region (2021-2026) Table 49. Global Pharma Grade Polyvinylpyrrolidone Sales by Region (2027-2032) & (t) Table 50. Global Pharma Grade Polyvinylpyrrolidone Sales Market Share by Region (2027-2032) Table 51. Global Pharma Grade Polyvinylpyrrolidone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Pharma Grade Polyvinylpyrrolidone Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Pharma Grade Polyvinylpyrrolidone Sales Value Share by Region (2021-2026) Table 54. Global Pharma Grade Polyvinylpyrrolidone Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Pharma Grade Polyvinylpyrrolidone Sales Value Share by Region (2027-2032) Table 56. Global Pharma Grade Polyvinylpyrrolidone Market Average Price (USD/t) by Region (2021-2026) Table 57. Global Pharma Grade Polyvinylpyrrolidone Market Average Price (USD/t) by Region (2027-2032) Table 58. Global Pharma Grade Polyvinylpyrrolidone Sales by Country: 2021 VS 2025 VS 2032 (t) Table 59. Global Pharma Grade Polyvinylpyrrolidone Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Pharma Grade Polyvinylpyrrolidone Sales by Country (2021-2026) & (t) Table 61. Global Pharma Grade Polyvinylpyrrolidone Sales Market Share by Country (2021-2026) Table 62. Global Pharma Grade Polyvinylpyrrolidone Sales by Country (2027-2032) & (t) Table 63. Global Pharma Grade Polyvinylpyrrolidone Sales Market Share by Country (2027-2032) Table 64. Global Pharma Grade Polyvinylpyrrolidone Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Pharma Grade Polyvinylpyrrolidone Sales Value Market Share by Country (2021-2026) Table 66. Global Pharma Grade Polyvinylpyrrolidone Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Pharma Grade Polyvinylpyrrolidone Sales Value Market Share by Country (2027-2032) Table 68. BASF Company Information Table 69. BASF Business Overview Table 70. BASF Pharma Grade Polyvinylpyrrolidone Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 71. BASF Pharma Grade Polyvinylpyrrolidone Product Portfolio Table 72. BASF Recent Development Table 73. Ashland Company Information Table 74. Ashland Business Overview Table 75. Ashland Pharma Grade Polyvinylpyrrolidone Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 76. Ashland Pharma Grade Polyvinylpyrrolidone Product Portfolio Table 77. Ashland Recent Development Table 78. Boai NKY Medical Holdings Company Information Table 79. Boai NKY Medical Holdings Business Overview Table 80. Boai NKY Medical Holdings Pharma Grade Polyvinylpyrrolidone Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 81. Boai NKY Medical Holdings Pharma Grade Polyvinylpyrrolidone Product Portfolio Table 82. Boai NKY Medical Holdings Recent Development Table 83. JH Nanhang Life Sciences Company Information Table 84. JH Nanhang Life Sciences Business Overview Table 85. JH Nanhang Life Sciences Pharma Grade Polyvinylpyrrolidone Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 86. JH Nanhang Life Sciences Pharma Grade Polyvinylpyrrolidone Product Portfolio Table 87. JH Nanhang Life Sciences Recent Development Table 88. Chongqing Star-Tech Specialty Products Company Information Table 89. Chongqing Star-Tech Specialty Products Business Overview Table 90. Chongqing Star-Tech Specialty Products Pharma Grade Polyvinylpyrrolidone Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 91. Chongqing Star-Tech Specialty Products Pharma Grade Polyvinylpyrrolidone Product Portfolio Table 92. Chongqing Star-Tech Specialty Products Recent Development Table 93. Huangshan Bonsun Pharmaceuticals Company Information Table 94. Huangshan Bonsun Pharmaceuticals Business Overview Table 95. Huangshan Bonsun Pharmaceuticals Pharma Grade Polyvinylpyrrolidone Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 96. Huangshan Bonsun Pharmaceuticals Pharma Grade Polyvinylpyrrolidone Product Portfolio Table 97. Huangshan Bonsun Pharmaceuticals Recent Development Table 98. Shanghai Yuking Water Soluble Material Tech Company Information Table 99. Shanghai Yuking Water Soluble Material Tech Business Overview Table 100. Shanghai Yuking Water Soluble Material Tech Pharma Grade Polyvinylpyrrolidone Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 101. Shanghai Yuking Water Soluble Material Tech Pharma Grade Polyvinylpyrrolidone Product Portfolio Table 102. Shanghai Yuking Water Soluble Material Tech Recent Development Table 103. Shanghai Qifuqing Material Technology Company Information Table 104. Shanghai Qifuqing Material Technology Business Overview Table 105. Shanghai Qifuqing Material Technology Pharma Grade Polyvinylpyrrolidone Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 106. Shanghai Qifuqing Material Technology Pharma Grade Polyvinylpyrrolidone Product Portfolio Table 107. Shanghai Qifuqing Material Technology Recent Development Table 108. Jiaozuo Zhongwei Special Products Pharmaceutical Company Information Table 109. Jiaozuo Zhongwei Special Products Pharmaceutical Business Overview Table 110. Jiaozuo Zhongwei Special Products Pharmaceutical Pharma Grade Polyvinylpyrrolidone Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 111. Jiaozuo Zhongwei Special Products Pharmaceutical Pharma Grade Polyvinylpyrrolidone Product Portfolio Table 112. Jiaozuo Zhongwei Special Products Pharmaceutical Recent Development Table 113. CNSIG Anhui Hongsifang Fertilizer Company Information Table 114. CNSIG Anhui Hongsifang Fertilizer Business Overview Table 115. CNSIG Anhui Hongsifang Fertilizer Pharma Grade Polyvinylpyrrolidone Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 116. CNSIG Anhui Hongsifang Fertilizer Pharma Grade Polyvinylpyrrolidone Product Portfolio Table 117. CNSIG Anhui Hongsifang Fertilizer Recent Development Table 118. Key Raw Materials Table 119. Raw Materials Key Suppliers Table 120. Pharma Grade Polyvinylpyrrolidone Distributors List Table 121. Pharma Grade Polyvinylpyrrolidone Customers List Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Pharma Grade Polyvinylpyrrolidone Product Image Figure 2. Global Pharma Grade Polyvinylpyrrolidone Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharma Grade Polyvinylpyrrolidone Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pharma Grade Polyvinylpyrrolidone Sales (2021-2032) & (t) Figure 5. Global Pharma Grade Polyvinylpyrrolidone Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Pharma Grade Polyvinylpyrrolidone Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. K17 Image Figure 10. K25 Image Figure 11. K30 Image Figure 12. K90 Image Figure 13. Other Image Figure 14. Global Pharma Grade Polyvinylpyrrolidone Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 15. Global Pharma Grade Polyvinylpyrrolidone Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Pharma Grade Polyvinylpyrrolidone Sales Volume Share by Type (2021-2032) Figure 17. Global Pharma Grade Polyvinylpyrrolidone Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Pharma Grade Polyvinylpyrrolidone Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type (2021-2032) Figure 20. Oral Preparations Image Figure 21. Injectable Preparations Image Figure 22. Topical Preparations Image Figure 23. Others Image Figure 24. Global Pharma Grade Polyvinylpyrrolidone Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 25. Global Pharma Grade Polyvinylpyrrolidone Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Pharma Grade Polyvinylpyrrolidone Sales Volume Share by Application (2021-2032) Figure 27. Global Pharma Grade Polyvinylpyrrolidone Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Pharma Grade Polyvinylpyrrolidone Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application (2021-2032) Figure 30. Global Pharma Grade Polyvinylpyrrolidone Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 31. Global Pharma Grade Polyvinylpyrrolidone Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Pharma Grade Polyvinylpyrrolidone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Pharma Grade Polyvinylpyrrolidone Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Pharma Grade Polyvinylpyrrolidone Sales Value (2021-2032) & (US$ Million) Figure 35. North America Pharma Grade Polyvinylpyrrolidone Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Pharma Grade Polyvinylpyrrolidone Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Pharma Grade Polyvinylpyrrolidone Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Pharma Grade Polyvinylpyrrolidone Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Pharma Grade Polyvinylpyrrolidone Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Pharma Grade Polyvinylpyrrolidone Sales Value (2021-2032) & (US$ Million) Figure 41. South America Pharma Grade Polyvinylpyrrolidone Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Pharma Grade Polyvinylpyrrolidone Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Pharma Grade Polyvinylpyrrolidone Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Pharma Grade Polyvinylpyrrolidone Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Pharma Grade Polyvinylpyrrolidone Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • K17
  • K25
  • K30
  • K90
  • Other
Applications
  • Oral Preparations
  • Injectable Preparations
  • Topical Preparations
  • Others
Companies covered
  • BASF
  • Ashland
  • Boai NKY Medical Holdings
  • JH Nanhang Life Sciences
  • Chongqing Star-Tech Specialty Products
  • Huangshan Bonsun Pharmaceuticals
  • Shanghai Yuking Water Soluble Material Tech
  • Shanghai Qifuqing Material Technology
  • Jiaozuo Zhongwei Special Products Pharmaceutical
  • CNSIG Anhui Hongsifang Fertilizer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pharma Grade Polyvinylpyrrolidone Sales Value (2021-2032)
  4. 1.2.2 Global Pharma Grade Polyvinylpyrrolidone Sales Volume (2021-2032)
  5. 1.2.3 Global Pharma Grade Polyvinylpyrrolidone Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pharma Grade Polyvinylpyrrolidone Market Dynamics
  1. 2.1 Pharma Grade Polyvinylpyrrolidone Industry Trends
  2. 2.2 Pharma Grade Polyvinylpyrrolidone Industry Drivers
  3. 2.3 Pharma Grade Polyvinylpyrrolidone Industry Opportunities and Challenges
  4. 2.4 Pharma Grade Polyvinylpyrrolidone Industry Restraints
3 Pharma Grade Polyvinylpyrrolidone Market by Company
  1. 3.1 Global Pharma Grade Polyvinylpyrrolidone Company Revenue Ranking in 2025
  2. 3.2 Global Pharma Grade Polyvinylpyrrolidone Revenue by Company (2021-2026)
  3. 3.3 Global Pharma Grade Polyvinylpyrrolidone Sales Volume by Company (2021-2026)
  4. 3.4 Global Pharma Grade Polyvinylpyrrolidone Average Price by Company (2021-2026)
  5. 3.5 Global Pharma Grade Polyvinylpyrrolidone Company Ranking (2024-2026)
  6. 3.6 Global Pharma Grade Polyvinylpyrrolidone Company Manufacturing Base and Headquarters
  7. 3.7 Global Pharma Grade Polyvinylpyrrolidone Company Product Type and Application
  8. 3.8 Global Pharma Grade Polyvinylpyrrolidone Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pharma Grade Polyvinylpyrrolidone Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pharma Grade Polyvinylpyrrolidone Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pharma Grade Polyvinylpyrrolidone Market by Type
  1. 4.1 Pharma Grade Polyvinylpyrrolidone Type Introduction
  2. 4.1.1 K17
  3. 4.1.2 K25
  4. 4.1.3 K30
  5. 4.1.4 K90
  6. 4.1.5 Other
  7. 4.2 Global Pharma Grade Polyvinylpyrrolidone Sales Volume by Type
  8. 4.2.1 Global Pharma Grade Polyvinylpyrrolidone Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Pharma Grade Polyvinylpyrrolidone Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Pharma Grade Polyvinylpyrrolidone Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Pharma Grade Polyvinylpyrrolidone Sales Value by Type
  12. 4.3.1 Global Pharma Grade Polyvinylpyrrolidone Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Pharma Grade Polyvinylpyrrolidone Sales Value by Type (2021-2032)
  14. 4.3.3 Global Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type (2021-2032)
5 Pharma Grade Polyvinylpyrrolidone Market by Application
  1. 5.1 Pharma Grade Polyvinylpyrrolidone Application Introduction
  2. 5.1.1 Oral Preparations
  3. 5.1.2 Injectable Preparations
  4. 5.1.3 Topical Preparations
  5. 5.1.4 Others
  6. 5.2 Global Pharma Grade Polyvinylpyrrolidone Sales Volume by Application
  7. 5.2.1 Global Pharma Grade Polyvinylpyrrolidone Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Pharma Grade Polyvinylpyrrolidone Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Pharma Grade Polyvinylpyrrolidone Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Pharma Grade Polyvinylpyrrolidone Sales Value by Application
  11. 5.3.1 Global Pharma Grade Polyvinylpyrrolidone Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Pharma Grade Polyvinylpyrrolidone Sales Value by Application (2021-2032)
  13. 5.3.3 Global Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application (2021-2032)
6 Pharma Grade Polyvinylpyrrolidone Regional Sales and Value Analysis
  1. 6.1 Global Pharma Grade Polyvinylpyrrolidone Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharma Grade Polyvinylpyrrolidone Sales by Region (2021-2032)
  3. 6.2.1 Global Pharma Grade Polyvinylpyrrolidone Sales by Region: 2021-2026
  4. 6.2.2 Global Pharma Grade Polyvinylpyrrolidone Sales by Region (2027-2032)
  5. 6.3 Global Pharma Grade Polyvinylpyrrolidone Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pharma Grade Polyvinylpyrrolidone Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pharma Grade Polyvinylpyrrolidone Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pharma Grade Polyvinylpyrrolidone Sales Value by Region (2027-2032)
  9. 6.5 Global Pharma Grade Polyvinylpyrrolidone Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pharma Grade Polyvinylpyrrolidone Sales Value (2021-2032)
  12. 6.6.2 North America Pharma Grade Polyvinylpyrrolidone Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pharma Grade Polyvinylpyrrolidone Sales Value (2021-2032)
  15. 6.7.2 Europe Pharma Grade Polyvinylpyrrolidone Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pharma Grade Polyvinylpyrrolidone Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pharma Grade Polyvinylpyrrolidone Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pharma Grade Polyvinylpyrrolidone Sales Value (2021-2032)
  21. 6.9.2 South America Pharma Grade Polyvinylpyrrolidone Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pharma Grade Polyvinylpyrrolidone Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pharma Grade Polyvinylpyrrolidone Sales Value Share by Country, 2025 VS 2032
7 Pharma Grade Polyvinylpyrrolidone Country-level Sales and Value Analysis
  1. 7.1 Global Pharma Grade Polyvinylpyrrolidone Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharma Grade Polyvinylpyrrolidone Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pharma Grade Polyvinylpyrrolidone Sales by Country (2021-2032)
  4. 7.3.1 Global Pharma Grade Polyvinylpyrrolidone Sales by Country (2021-2026)
  5. 7.3.2 Global Pharma Grade Polyvinylpyrrolidone Sales by Country (2027-2032)
  6. 7.4 Global Pharma Grade Polyvinylpyrrolidone Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pharma Grade Polyvinylpyrrolidone Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pharma Grade Polyvinylpyrrolidone Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pharma Grade Polyvinylpyrrolidone Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pharma Grade Polyvinylpyrrolidone Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pharma Grade Polyvinylpyrrolidone Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 BASF
  2. 8.1.1 BASF Company Information
  3. 8.1.2 BASF Business Overview
  4. 8.1.3 BASF Pharma Grade Polyvinylpyrrolidone Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 BASF Pharma Grade Polyvinylpyrrolidone Product Portfolio
  6. 8.1.5 BASF Recent Developments
  7. 8.2 Ashland
  8. 8.2.1 Ashland Company Information
  9. 8.2.2 Ashland Business Overview
  10. 8.2.3 Ashland Pharma Grade Polyvinylpyrrolidone Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Ashland Pharma Grade Polyvinylpyrrolidone Product Portfolio
  12. 8.2.5 Ashland Recent Developments
  13. 8.3 Boai NKY Medical Holdings
  14. 8.3.1 Boai NKY Medical Holdings Company Information
  15. 8.3.2 Boai NKY Medical Holdings Business Overview
  16. 8.3.3 Boai NKY Medical Holdings Pharma Grade Polyvinylpyrrolidone Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Boai NKY Medical Holdings Pharma Grade Polyvinylpyrrolidone Product Portfolio
  18. 8.3.5 Boai NKY Medical Holdings Recent Developments
  19. 8.4 JH Nanhang Life Sciences
  20. 8.4.1 JH Nanhang Life Sciences Company Information
  21. 8.4.2 JH Nanhang Life Sciences Business Overview
  22. 8.4.3 JH Nanhang Life Sciences Pharma Grade Polyvinylpyrrolidone Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 JH Nanhang Life Sciences Pharma Grade Polyvinylpyrrolidone Product Portfolio
  24. 8.4.5 JH Nanhang Life Sciences Recent Developments
  25. 8.5 Chongqing Star-Tech Specialty Products
  26. 8.5.1 Chongqing Star-Tech Specialty Products Company Information
  27. 8.5.2 Chongqing Star-Tech Specialty Products Business Overview
  28. 8.5.3 Chongqing Star-Tech Specialty Products Pharma Grade Polyvinylpyrrolidone Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Chongqing Star-Tech Specialty Products Pharma Grade Polyvinylpyrrolidone Product Portfolio
  30. 8.5.5 Chongqing Star-Tech Specialty Products Recent Developments
  31. 8.6 Huangshan Bonsun Pharmaceuticals
  32. 8.6.1 Huangshan Bonsun Pharmaceuticals Company Information
  33. 8.6.2 Huangshan Bonsun Pharmaceuticals Business Overview
  34. 8.6.3 Huangshan Bonsun Pharmaceuticals Pharma Grade Polyvinylpyrrolidone Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Huangshan Bonsun Pharmaceuticals Pharma Grade Polyvinylpyrrolidone Product Portfolio
  36. 8.6.5 Huangshan Bonsun Pharmaceuticals Recent Developments
  37. 8.7 Shanghai Yuking Water Soluble Material Tech
  38. 8.7.1 Shanghai Yuking Water Soluble Material Tech Company Information
  39. 8.7.2 Shanghai Yuking Water Soluble Material Tech Business Overview
  40. 8.7.3 Shanghai Yuking Water Soluble Material Tech Pharma Grade Polyvinylpyrrolidone Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Shanghai Yuking Water Soluble Material Tech Pharma Grade Polyvinylpyrrolidone Product Portfolio
  42. 8.7.5 Shanghai Yuking Water Soluble Material Tech Recent Developments
  43. 8.8 Shanghai Qifuqing Material Technology
  44. 8.8.1 Shanghai Qifuqing Material Technology Company Information
  45. 8.8.2 Shanghai Qifuqing Material Technology Business Overview
  46. 8.8.3 Shanghai Qifuqing Material Technology Pharma Grade Polyvinylpyrrolidone Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Shanghai Qifuqing Material Technology Pharma Grade Polyvinylpyrrolidone Product Portfolio
  48. 8.8.5 Shanghai Qifuqing Material Technology Recent Developments
  49. 8.9 Jiaozuo Zhongwei Special Products Pharmaceutical
  50. 8.9.1 Jiaozuo Zhongwei Special Products Pharmaceutical Company Information
  51. 8.9.2 Jiaozuo Zhongwei Special Products Pharmaceutical Business Overview
  52. 8.9.3 Jiaozuo Zhongwei Special Products Pharmaceutical Pharma Grade Polyvinylpyrrolidone Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Jiaozuo Zhongwei Special Products Pharmaceutical Pharma Grade Polyvinylpyrrolidone Product Portfolio
  54. 8.9.5 Jiaozuo Zhongwei Special Products Pharmaceutical Recent Developments
  55. 8.10 CNSIG Anhui Hongsifang Fertilizer
  56. 8.10.1 CNSIG Anhui Hongsifang Fertilizer Company Information
  57. 8.10.2 CNSIG Anhui Hongsifang Fertilizer Business Overview
  58. 8.10.3 CNSIG Anhui Hongsifang Fertilizer Pharma Grade Polyvinylpyrrolidone Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 CNSIG Anhui Hongsifang Fertilizer Pharma Grade Polyvinylpyrrolidone Product Portfolio
  60. 8.10.5 CNSIG Anhui Hongsifang Fertilizer Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pharma Grade Polyvinylpyrrolidone Value Chain Analysis
  2. 9.1.1 Pharma Grade Polyvinylpyrrolidone Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pharma Grade Polyvinylpyrrolidone Sales Mode & Process
  6. 9.2 Pharma Grade Polyvinylpyrrolidone Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pharma Grade Polyvinylpyrrolidone Distributors
  9. 9.2.3 Pharma Grade Polyvinylpyrrolidone Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst